These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14664344)

  • 1. Comparison of the Gordon-Taylor and Couchman-Karasz equations for prediction of the glass transition temperature of glass solutions of drug and polyvinylpyrrolidone prepared by melt extrusion.
    Forster A; Hempenstall J; Rades T
    Pharmazie; 2003 Nov; 58(11):838-9. PubMed ID: 14664344
    [No Abstract]   [Full Text] [Related]  

  • 2. The potential of small-scale fusion experiments and the Gordon-Taylor equation to predict the suitability of drug/polymer blends for melt extrusion.
    Forster A; Hempenstall J; Tucker ; Rades T
    Drug Dev Ind Pharm; 2001 Jul; 27(6):549-60. PubMed ID: 11548862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of glass solutions of poorly water-soluble drugs produced by melt extrusion with hydrophilic amorphous polymers.
    Forster A; Hempenstall J; Rades T
    J Pharm Pharmacol; 2001 Mar; 53(3):303-15. PubMed ID: 11291745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of drug-polymer solubility curves through formal statistical analysis: comparison of preparation techniques.
    Knopp MM; Olesen NE; Holm P; Löbmann K; Holm R; Langguth P; Rades T
    J Pharm Sci; 2015 Jan; 104(1):44-51. PubMed ID: 25363890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility.
    Marsac PJ; Shamblin SL; Taylor LS
    Pharm Res; 2006 Oct; 23(10):2417-26. PubMed ID: 16933098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling.
    Patterson JE; James MB; Forster AH; Lancaster RW; Butler JM; Rades T
    Int J Pharm; 2007 May; 336(1):22-34. PubMed ID: 17174493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of copolymer composition on the phase behavior of solid dispersions.
    Prudic A; Kleetz T; Korf M; Ji Y; Sadowski G
    Mol Pharm; 2014 Nov; 11(11):4189-98. PubMed ID: 25295846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound-compacted indomethacin/polyvinylpyrrolidone systems: effect of compaction process on particle morphology and dissolution behavior.
    Fini A; Holgado MA; Rodriguez L; Cavallari C
    J Pharm Sci; 2002 Aug; 91(8):1880-90. PubMed ID: 12115815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration.
    Chokshi RJ; Shah NH; Sandhu HK; Malick AW; Zia H
    J Pharm Sci; 2008 Jun; 97(6):2286-98. PubMed ID: 17879977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Water vapor absorption into amorphous hydrophobic drug/poly(vinylpyrrolidone) dispersions.
    Crowley KJ; Zografi G
    J Pharm Sci; 2002 Oct; 91(10):2150-65. PubMed ID: 12226842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the physical stability of amorphous felodipine and nifedipine systems.
    Marsac PJ; Konno H; Taylor LS
    Pharm Res; 2006 Oct; 23(10):2306-16. PubMed ID: 16927182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion processs as a means to manufacture solid dispersion/solution.
    Chokshi RJ; Sandhu HK; Iyer RM; Shah NH; Malick AW; Zia H
    J Pharm Sci; 2005 Nov; 94(11):2463-74. PubMed ID: 16200544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing beta relaxation in pharmaceutically relevant glasses by using DSC.
    Vyazovkin S; Dranca I
    Pharm Res; 2006 Feb; 23(2):422-8. PubMed ID: 16388410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of moisture uptake effects on the glass transitional behaviour of an amorphous drug using modulated temperature DSC.
    Royall PG; Craig DQ; Doherty C
    Int J Pharm; 1999 Dec; 192(1):39-46. PubMed ID: 10572197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical evaluation of PVP-thiazide diuretic interactions in co-spray-dried composites--analysis of glass transition composition relationships.
    Tajber L; Corrigan OI; Healy AM
    Eur J Pharm Sci; 2005 Apr; 24(5):553-63. PubMed ID: 15784345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubilization and interaction of sulindac with polyvinylpyrrolidone K30 in the solid state and in aqueous solution.
    Tros de Ilarduya MC; Martín C; Goñi MM; Martínez-Ohárriz MC
    Drug Dev Ind Pharm; 1998 Mar; 24(3):295-300. PubMed ID: 9876588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sudden rise of crystal growth rate of nifedipine near T(g) without and with polyvinylpyrrolidone.
    Ishida H; Wu T; Yu L
    J Pharm Sci; 2007 May; 96(5):1131-8. PubMed ID: 17455342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the physicochemical characteristics of crospovidone that influence solid dispersion preparation.
    Nakanishi S; Fujii M; Sugamura Y; Suzuki A; Shibata Y; Koizumi N; Watanabe Y
    Int J Pharm; 2011 Jul; 413(1-2):119-25. PubMed ID: 21549186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of storage conditions on the free volume of polyvinylpyrrolidone: comparison of positron lifetime data with the tensile strength of tablets.
    Zelkó R; Süvegh K; Marton S; Rácz I
    Pharm Res; 2000 Aug; 17(8):1030-2. PubMed ID: 11028953
    [No Abstract]   [Full Text] [Related]  

  • 20. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.